| Epidemiology and burden of HPV infection and related diseases: implications for prevention strategies JE Tota, M Chevarie-Davis, LA Richardson, M Devries, EL Franco Preventive medicine 53, S12-S21, 2011 | 386 | 2011 |
| Rising incidence of oral tongue cancer among white men and women in the United States, 1973–2012 JE Tota, WF Anderson, C Coffey, J Califano, W Cozen, RL Ferris, ... Oral oncology 67, 146-152, 2017 | 189 | 2017 |
| Evolution of the oropharynx cancer epidemic in the United States: moderation of increasing incidence in younger individuals and shift in the burden to older individuals JE Tota, AF Best, ZS Zumsteg, ML Gillison, PS Rosenberg, AK Chaturvedi Journal of Clinical Oncology 37 (18), 1538-1546, 2019 | 151 | 2019 |
| Introduction of molecular HPV testing as the primary technology in cervical cancer screening: Acting on evidence to change the current paradigm JE Tota, J Bentley, J Blake, F Coutlée, MA Duggan, A Ferenczy, ... Preventive Medicine 98, 5-14, 2017 | 132 | 2017 |
| The expected impact of HPV vaccination on the accuracy of cervical cancer screening: the need for a paradigm change EL Franco, SM Mahmud, J Tota, A Ferenczy, F Coutlée Archives of medical research 40 (6), 478-485, 2009 | 132 | 2009 |
| Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination JE Tota, AV Ramanakumar, M Jiang, J Dillner, SD Walter, JS Kaufman, ... American journal of epidemiology 178 (4), 625-634, 2013 | 121 | 2013 |
| The road ahead for cervical cancer prevention and control JE Tota, AV Ramana–Kumar, Z El-Khatib, EL Franco Current oncology 21 (2), 255-264, 2014 | 75 | 2014 |
| Human papillomavirus-associated subsequent malignancies among long-term survivors of pediatric and young adult cancers RP Ojha, JE Tota, TN Offutt-Powell, JL Klosky, TD Minniear, BE Jackson, ... PloS one 8 (8), e70349, 2013 | 63 | 2013 |
| Summary from an international cancer seminar focused on human papillomavirus (HPV)-positive oropharynx cancer, convened by scientists at IARC and NCI AR Kreimer, AK Chaturvedi, L Alemany, D Anantharaman, F Bray, ... Oral oncology 108, 104736, 2020 | 59 | 2020 |
| The accuracy of human papillomavirus vaccination status based on adult proxy recall or household immunization records for adolescent females in the United States: results from … RP Ojha, JE Tota, TN Offutt-Powell, JL Klosky, R Ashokkumar, JG Gurney Annals of epidemiology 23 (5), 281-285, 2013 | 54 | 2013 |
| Evaluation of type replacement following HPV16/18 vaccination: pooled analysis of two randomized trials JE Tota, F Struyf, M Merikukka, P Gonzalez, AR Kreimer, D Bi, ... JNCI: Journal of the National Cancer Institute 109 (7), djw300, 2017 | 50 | 2017 |
| Lung cancer screening: review and performance comparison under different risk scenarios JE Tota, AV Ramanakumar, EL Franco Lung 192, 55-63, 2014 | 48 | 2014 |
| Efficacy of a Carrageenan gel Against Transmission of Cervical HPV (CATCH): Interim analysis of a randomized, double-blind, placebo-controlled, phase 2B trial S Magnan, JE Tota, M El-Zein, AN Burchell, JT Schiller, A Ferenczy, ... Clinical Microbiology and Infection 25 (2), 210-216, 2019 | 43 | 2019 |
| Guillain–Barre syndrome following quadrivalent human papillomavirus vaccination among vaccine-eligible individuals in the United States RP Ojha, BE Jackson, JE Tota, TN Offutt-Powell, KP Singh, S Bae Human vaccines & immunotherapeutics 10 (1), 232-237, 2014 | 43 | 2014 |
| Promising strategies for cervical cancer screening in the post-human papillomavirus vaccination era J Tota, SM Mahmud, A Ferenczy, F Coutlée, EL Franco Sexual Health 7 (3), 376-382, 2010 | 42 | 2010 |
| Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening JE Tota, J Bentley, J Blake, F Coutlée, MA Duggan, A Ferenczy, ... Preventive medicine 98, 15-20, 2017 | 41 | 2017 |
| Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens JE Tota, AV Ramanakumar, LL Villa, H Richardson, AN Burchell, ... Cancer Epidemiology, Biomarkers & Prevention 24 (1), 286-290, 2015 | 39 | 2015 |
| Optimizing technology for cervical cancer screening in high-resource settings LA Richardson, J Tota, EL Franco Expert review of obstetrics & gynecology 6 (3), 343-353, 2011 | 28 | 2011 |
| Development and validation of an individualized risk prediction model for oropharynx cancer in the US population JE Tota, ML Gillison, HA Katki, L Kahle, RK Pickard, W Xiao, B Jiang, ... Cancer 125 (24), 4407-4416, 2019 | 27 | 2019 |
| Efficacy of the AS04-adjuvanted HPV16/18 vaccine: pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials JE Tota, F Struyf, JN Sampson, P Gonzalez, M Ryser, R Herrero, ... JNCI: Journal of the National Cancer Institute 112 (8), 818-828, 2020 | 26 | 2020 |
